IDEAYA Biosciences, Inc. (IDYA)
33.85
-0.01
(-0.03%)
USD |
NASDAQ |
Oct 15, 16:00
33.51
-0.34
(-1.00%)
After-Hours: 20:00
IDEAYA Biosciences Cash from Operations (TTM) : -111.66M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -111.66M |
| March 31, 2026 | -85.93M |
| December 31, 2025 | -71.10M |
| September 30, 2025 | -102.26M |
| June 30, 2025 | -293.70M |
| March 31, 2025 | -264.11M |
| December 31, 2024 | -247.58M |
| September 30, 2024 | -149.68M |
| June 30, 2024 | -130.62M |
| March 31, 2024 | -131.20M |
| December 31, 2023 | -115.22M |
| September 30, 2023 | -114.85M |
| June 30, 2023 | -108.84M |
| March 31, 2023 | -95.37M |
| December 31, 2022 | -87.18M |
| September 30, 2022 | -80.46M |
| Date | Value |
|---|---|
| June 30, 2022 | -68.76M |
| March 31, 2022 | -61.70M |
| December 31, 2021 | -55.78M |
| September 30, 2021 | -50.72M |
| June 30, 2021 | 51.96M |
| March 31, 2021 | 51.28M |
| December 31, 2020 | 55.46M |
| September 30, 2020 | 58.35M |
| June 30, 2020 | -42.41M |
| March 31, 2020 | -39.07M |
| December 31, 2019 | -39.31M |
| September 30, 2019 | -38.08M |
| June 30, 2019 | -36.22M |
| March 31, 2019 | -31.88M |
| December 31, 2018 | -27.62M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Xencor, Inc. | -205.81M |
| BioMarin Pharmaceutical, Inc. | 857.09M |
| MediciNova, Inc. | -9.110M |
| Viking Therapeutics, Inc. | -418.44M |